36
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Formation and Stability of the Dispersed Particles Composed of Retinyl Palmitate and Phosphatidylcholine

&
Pages 39-45 | Received 29 Sep 1998, Accepted 03 Jun 1999, Published online: 18 Jan 2000
 

Abstract

The purpose of this study was to develop an intravenous formulation composed of retinyl palmitate (RP) for the treatment of cancer. RP was dispersed with soybean phosphatidylcholine (PC) using sonication and the dispersal mechanism was evaluated by characterizing the dispersed particles using dynamic light-scattering, fluorescence spectroscopy, and surface monolayer techniques. The dispersions in the RP mole fraction range of 0.1–0.8 were stable at room temperature for 3 days. A limited amount of RP was incorporated into PC bilayer membranes (approximately 3 mol%). The excess RP separated from the PC bilayers was stabilized as emulsion particles by the PC surface monolayer. When the PC content was less than the solubility in RP, the PC monolayer did not completely cover the hydrophobic RP particle surfaces and separation into oil/water occurred. The miscibility between RP and PC and the lipid composition were critically important for the stability of the dispersed particles (coexistence of emulsion particles [surface monolayer of PC pl core of RP] with vesicular particles [bilayer]) of the lipid mixtures.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.